Description: Join a discussion on the tax implications for direct writers ceding annuity blocks for both onshore and offshore reinsurance arrangements. Get an introduction to the tax consequences of the risk transfer of annuity features and guarantees to reinsurers to reinsurers that are U.S.-based and not U.S. domiciled.

Description: Join us for discussion about the tax implications for direct writers ceding annuity blocks. The presenters will describe the mechanics and consequences for both onshore and offshore reinsurance arrangements. This will introduce the audience to the tax consequences, with the risk transfer of annuity features and guarantees to reinsurers to reinsurers that are US-based and not US domiciled.

Description: Discuss a comparison of the U.S. general and insured population mortality experience and how COVID-19 and non-COVID-19 excess deaths impacted the populations differently. Discover the population mortality experience in the UK with a focus on the recent emergence of excess deaths for non-COVID causes. The long-term implications on the insured population will also be explored. Wrap up with a discussion of different conditions of long COVID, including organ impairments.

Description: 2021 Life Meeting - Session 1C: Earnings Pressure Impact on Annuity Product Development and the Insurance-Linked Securities Market

Description: Despite its significance, longevity risk in the U.S. market has historically received fairly little attention, especially in international comparison, but the tide seems to be turning.

Description: The Society of Actuaries is committed to fostering a more inclusive and diverse environment in the U.S. and elsewhere around the world for members, candidates and customers wherever they live. An important aspect of this commitment is dedicated research that the Society of Actuaries has sponsored to further advance this effort. Explore diversity, equity and inclusion issues from the aspect of retirement preparedness and other aging issues. Results from a recently released research report and author's views from an invitation to write essays on these issues will be presented with an opportunity for audience suggestions for future work.

Description: Back by popular demand, it is that time of year for this well-liked annual webcast. Get ready to hear from three expert speakers, who will be covering the latest considerations for the year's U.S. statutory financial reporting work. 2021 has proven to have been quite remarkable, providing many important topics to be discussed.

Description: The U.S. life insurance industry has been increasing its exposure to complex assets, either directly as investors or via offshore reinsurance (e.g., Bermuda). In order to address regulatory concerns about such investments and reinsurance arrangements, the NAIC has begun multiple initiatives to improve disclosure and strengthen regulatory requirements, and the Bermuda Monetary Authority is also strengthening its requirements. Hear a summary of these initiatives, and get an update on the latest developments at the NAIC and at the Academy on these topics.

Description: Gene therapy is a quickly evolving field and will continue to grow as a risk concern for many health plans, stop loss insurers and reinsurers. Currently, there are only two approved gene therapies in the U.S., but that number is expected to escalate starting in the fall of 2022. Revisit the experience plans have had with the first two gene therapies, discuss plan design and network considerations in light of gene therapy, and discuss the actual composition of the near-term pipeline along with a range of modeled financial impacts and considerations for payers.

Description: Both under favorable and stressed conditions, companies heavily rely on reinsurance and the market has seen a number of major transactions enacted in this space over recent months. Reinsurance offers a wider variety of opportunities in order to manage stressed balance sheets and enhance return on capital, upon which insurers must continually reflect in order to capture all the potential value. For example, captive reinsurance, which offers expense or cost reduction advantages in addition to risk management and control, is becoming more widespread as more U.S. jurisdictions allow parents companies to benefit from these captive formations. Upon enacting a transaction, ensuring the implementation of effective reinsurance operations is crucial in order to avoid operational inefficiencies and monitor the transaction's performance. Understanding the potential opportunities and common pitfalls in reinsurance processes is vital for capturing the full value of reinsurance. By attending the session, you will: Explore all the options available where reinsurance can be leveraged to improve capital and tax position, as well as achieving the optimal balance of risk appetite and underwriting profit. Furthermore, the presentation will provide real life case studies on how innovation and operational excellence can improve earnings by reducing costs related to inefficiencies, reducing process timing, improving controls, and reducing reinsurance leakage.